A digital therapeutic (DTx) is defined as “health software intended to treat or alleviate a disease, disorder, condition, or injury by generating and delivering a medical intervention that has a ...

Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type in the US for preventing attacks in people with episodic migraine.

With CSL Seqirus and Arcturus Therapeutics successfully developing the first approved self-amplifying RNA vaccine, the field of next generation RNAs celebrates the potential of circular and ...

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United ...

The Halozyme Therapeutics Inc.-Bond has a maturity date of 3/1/2027 and offers a coupon of 0.2500%. The payment of the coupon will take place 2,0 times per biannual on the 01.09.. The Halozyme ...

Denali Therapeutics Inc. 161 Oyster Point Boulevard San Francisco, California 94080 Phone 1 650 866-8547 Industry Biotechnology Sector Health Care/Life Sciences Fiscal Year-end 12/2025 Revenue N/A ...